Abstract：Both of genetic and environmental factors play important roles in the pathogenesis of attention deficit hyperactivity disorder (ADHD), and genetic factors can increase the susceptibility of individuals to environmental risk factors. There are extensive and various structural and functional abnormalities of the brain in patients with ADHD. Given the close functional relationship between brain areas, exploration has also been expanded to the dysfunction of brain network in recent years. As for the biochemical mechanism underlying ADHD, monoamine neurotransmitters are still most valued, and abnormalities of brain-derived neurotrophic factors and glutamic acid/γ-aminobutyric acid imbalance may also be present. Due to the abnormal neuroendocrine function and connectivity between brain areas caused by the synergistic effect of genetic and environmental factors, the prefrontal cortex loses control of the lower brain areas, so that the basal ganglia and amygdala affect normal behavioral and emotional reactions. Dysfunction of the endocrine axes may further aggravate neuroendocrine disorder. The above process may eventually lead to changes in brain structure and function, which may be associated with the development of ADHD. However, considering the heterogeneity of ADHD, its pathological process may not be the same, and the exact mechanism needs to be further clarified.
Thapar A, Cooper M. Attention deficit hyperactivity disorder[J]. Lacent, 2016, 387(10024):1240-1250.
[2]
Sharma A, Couture J. A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)[J]. Ann Pharmacother, 2014, 48(2):209-225.
[3]
Caye A, Spadini AV, Karam RG, et al. Predictors of persistence of ADHD into adulthood:a systematic review of the literature and meta-analysis[J]. Eur Child Adolesc Psychiatry, 2016, 25(11):1151-1159.
[4]
Matthies S, Philipsen A. Comorbidity of personality disorders and adult attention deficit hyperactivity disorder (ADHD)-review of recent findings[J]. Curr Psychiatry Rep, 2016, 18(4):33.
[5]
Punja S, Shamseer L, Hartling L, et al. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents[J]. Cochrane Database Syst Rev, 2016, 2:CD009996.
[6]
Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents:a systematic review[J]. JAMA, 2016, 315(18):1997-2008.
[7]
Kawaura K, Karasawa J, Chaki S, et al. Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder[J]. Behav Brain Res, 2014, 270:349-356.
[8]
Faraone SV, Bonvicini C, Scassellati C. Biomarkers in the diagnosis of ADHD-promising directions[J]. Curr Psychiatry Rep, 2014, 16(11):497.
[9]
Hawi Z, Cummins TD, Tong J, et al. The molecular genetic architecture of attention deficit hyperactivity disorder[J]. Mol Psychiatry, 2015, 20(3):289-297.
[10]
Yang L, Chang S, Lu Q, et al. A new locus regulating MICALL2 expression was identified for association with executive inhibition in children with attention deficit hyperactivity disorder[J]. Mol Psychiatry, 2018, 23(4):1014-1020.
[11]
Bath KG, Manzano-Nieves G, Goodwill H. Early life stress accelerates behavioral and neural maturation of the hippocampus in male mice[J]. Horm Behav, 2016, 82:64-71.
[12]
Raz S, Leykin D. Psychological and cortisol reactivity to experimentally induced stress in adults with ADHD[J]. Psychoneuroendocrinology, 2015, 60:7-17.
[13]
Lundervold AJ, Hinshaw SP, Sørensen L, et al. Co-occurring symptoms of attention deficit hyperactivity disorder (ADHD) in a population-based sample of adolescents screened for depression[J]. BMC Psychiatry, 2016, 16:46.
[14]
Smith TF, Schmidt-Kastner R, McGeary JE, et al. Pre-and perinatal ischemia-hypoxia, the ischemia-hypoxia response pathway, and ADHD risk[J]. Behav Genet, 2016, 46(3):467-477.
[15]
Hiroi R, Carbone DL, Zuloaga DG, et al. Sex-dependent programming effects of prenatal glucocorticoid treatment on the developing serotonin system and stress-related behaviors in adulthood[J]. Neuroscience, 2016, 320:43-56.
[16]
Agha SS, Zammit S, Thapar A, et al. Maternal psychopathology and offspring clinical outcome:a four-year follow-up of boys with ADHD[J]. Eur Child Adolesc Psychiatry, 2017, 26(2):253-262.
[17]
Weston HI, Weston DD, Allen JL, et al. Sex-dependent impacts of low-level lead exposure and prenatal stress on impulsive choice behavior and associated biochemical and neurochemical manifestations[J]. Neurotoxicology, 2014, 44:169-183.
[18]
Wiggs KK, Chang Z, Quinn PD, et al. Attention-deficit/hyperactivity disorder medication and seizures[J]. Neurology, 2018, 90(13):e1104-e1110.
[19]
Packer RM, Law TH, Davies E, et al. Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy[J]. Epilepsy Behav, 2016, 55:62-68.
[20]
Dolina S, Margalit D, Malitsky S, et al. Attention-deficit hyperactivity disorder (ADHD) as a pyridoxine-dependent condition:urinary diagnostic biomarkers[J]. Med Hypotheses, 2014, 82(1):111-116.
[21]
Matheus FC, Rial D, Real JI, et al. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats[J]. Behav Brain Res, 2016, 301:43-54.
[22]
Dang LC, Samanez-Larkin GR, Young JS, et al. Caudate asymmetry is related to attentional impulsivity and an objective measure of ADHD-like attentional problems in healthy adults[J]. Brain Struct Funct, 2016, 221(1):277-286.
[23]
Ma I, Van Holstein M, Mies GW, et al. Ventral striatal hyperconnectivity during rewarded interference control in adolescents with ADHD[J]. Cortex, 2016, 82:225-236.
[24]
Onnink AM, Franke B, van Hulzen K, et al. Enlarged striatal volume in adults with ADHD carrying the 9-6 haplotype of the dopamine transporter gene DAT1[J]. J Neural Transm (Vienna), 2016, 123(8):905-915.
[25]
Van Waes V, Ehrlich S, Beverley JA, et al. Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways:potential role for 5-HT1B receptor[J]. Neuropharmacology, 2015, 89:77-86.
[26]
Luders E, Kurth F, Das D, et al. Associations between corpus callosum size and ADHD symptoms in older adults:The PATH through life study[J]. Psychiatry Res Neuroimaging, 2016, 256:8-14.
[27]
Svatkova A, Nestrasil I, Rudser K, et al. Unique white matter microstructural patterns in ADHD presentations-a diffusion tensor imaging study[J]. Hum Brain Mapp, 2016, 37(9):3323-3336.
[28]
Mohan A, Roberto AJ, Mohan A, et al. The significance of the default mode network (DMN) in neurological and neuropsychiatric disorders:a review[J]. Yale J Biol Med, 2016, 89(1):49-57.
[29]
McCarthy H, Skokauskas N, Frodl T. Attention network hypoconnectivity in adults diagnosed as having attention-deficit/hyperactivity disorder in childhood[J]. JAMA Psychiatry, 2014, 71(11):1299-1300.
[30]
Biskup CS, Helmbold K, Baurmann D, et al. Resting state default mode network connectivity in children and adolescents with ADHD after acute tryptophan depletion[J]. Acta Psychiatr Scand, 2016, 134(2):161-171.
[31]
Sun H, Chen Y, Huang Q, et al. Psychoradiologic utility of MR imaging for diagnosis of attention deficit hyperactivity disorder:a radiomics analysis[J]. Radiology, 2018, 287(2):620-630.
[32]
Karmakar A, Maitra S, Verma D, et al. Potential contribution of monoamine oxidase a gene variants in ADHD and behavioral co-morbidities:scenario in eastern Indian probands[J]. Neurochem Res, 2014, 39(5):843-852.
[33]
Vanicek T, Kutzelnigg A, Philippe C, et al. Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET[J]. Hum Brain Mapp, 2017, 38(2):792-802.
[34]
Baptista J, Belsky J, Mesquita A, et al. Serotonin transporter polymorphism moderates the effects of caregiver intrusiveness on ADHD symptoms among institutionalized preschoolers[J]. Eur Child Adolesc Psychiatry, 2017, 26(3):303-313.
[35]
Bezdudnaya T, Castro-Alamancos MA. Neuromodulation of whisking related neural activity in superior colliculus[J]. J Neurosci, 2014, 34(22):7683-7695.
[36]
Van Goozen SH, Langley K, Northover C, et al. Identifying mechanisms that underlie links between COMT genotype and aggression in male adolescents with ADHD[J]. J Child Psychol Psychiatry, 2016, 57(4):472-480.
[37]
Wang CC, Man GC, Chu CY, et al. Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos[J]. J Biol Chem, 2014, 289(12):8252-8263.
[38]
Ko CH, Hsieh TJ, Wang PW, et al. The altered brain activation of phonological working memory, dual tasking, and distraction among participants with adult ADHD and the effect of the MAOA polymorphism[J]. J Atten Disord, 2018, 22(3):240-249.
[39]
Hayes DJ, Jupp B, Sawiak SJ, et al. Brain γ-aminobutyric acid:a neglected role in impulsivity[J]. Eur J Neurosci, 2014, 39(11):1921-1932.
[40]
Purkayastha P, Malapati A, Yogeeswari P, et al. A review on GABA/glutamate pathway for therapeutic intervention of ASD and ADHD[J]. Curr Med Chem, 2015, 22(15):1850-1859.
[41]
Kass I, Hoke DE, Costa MG, et al. Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis[J]. Proc Natl Acad Sci U S A, 2014, 111(25):E2524-E2529.
[42]
Ji J, Chen T, Sundquist J, et al. Type 1 diabetes in parents and risk of attention deficit/hyperactivity disorder in offspring:a population-based study in Sweden[J]. Diabetes Care, 2018, 41(4):770-774.
[43]
Cubero-Millán I, Ruiz-Ramos MJ, Molina-Carballo A, et al. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology[J]. Psychopharmacology (Berl), 2017, 234(2):267-279.
[44]
Kim J, Wessling-Resnick M. Iron and mechanisms of emotional behavior[J]. J Nutr Biochem, 2014, 25(11):1101-1107.
[45]
Roozendaal B, Luyten L, de Voogd LD, et al. Importance of amygdala noradrenergic activity and large-scale neural networks in regulating emotional arousal effects on perception and memory[J]. Behav Brain Sci, 2016, 39:e222.
Rygula R, Clarke HF, Cardinal RN, et al. Role of central serotonin in anticipation of rewarding and punishing outcomes:effects of selective amygdala or orbitofrontal 5-HT depletion[J]. Cereb Cortex, 2015, 25(9):3064-3076.
